The Investor Bridging AI, Healthcare, and Clean Energy: Yazan Al Homsi’s 2026 Portfolio Shows Where Smart Capital is Heading
Yazan Al Homsi, a CFA charterholder and cross-border venture capitalist operating through Founders Round Capital in Vancouver and Catalyst Communications DMCC in Dubai, has positioned a portfolio across all three sectors.

Written By: BOSS Editorial
Reading Time: 5 minutes
A Portfolio Built on Structural Inefficiency
The most reliable investment opportunities tend to emerge not from hype cycles but from structural inefficiencies that technology can address at scale. In early 2026, three sectors are experiencing precisely this dynamic: chemical recycling is struggling to keep pace with regulatory mandates for circular plastics, rural healthcare systems face physician shortages that permanent infrastructure cannot solve economically, and education technology is being reshaped by AI capabilities that traditional classroom models cannot replicate.
Yazan Al Homsi, a CFA charterholder and cross-border venture capitalist operating through Founders Round Capital in Vancouver and Catalyst Communications DMCC in Dubai, has positioned a portfolio across all three sectors. His investments in Aduro Clean Technologies (NASDAQ: ADUR | CSE: ACT | FSE: 9D5), Rocket Doctor AI Inc. (CSE: AIDR | OTC: AIRDF | Frankfurt: 939), and EduMentors reflect a thesis that AI-enhanced platforms embedded in physical industries will outperform standalone AI applications over the current market cycle.
The first quarter of 2026 has delivered concurrent milestones across each holding, offering a window into how that thesis is playing out in practice.
Chemical Recycling: Aduro Moves from Data to Deals
Aduro Clean Technologies has entered initial operating campaigns at its Next Generation Process (NGP) Pilot Plant in London, Ontario, generating the structured, repeatable data required for commercial scale-up and first-of-a-kind (FOAK) facility engineering. The plant, which completed installations in December 2025, is now functioning as an integrated process unit with formally trained operators running continuous operations.
The commercial signals are equally significant. Aduro has announced participation in six industry events across four continents between March and April 2026, including presentations on steam cracker integration at AMI Chemical Recycling North America in Houston and FOAK facility planning at the GO CIRCULAR summit in Mannheim. A government-supported cleantech mission to South Korea adds institutional credibility for Asia-Pacific expansion. Recent reporting on Aduro’s advancement toward industrial-scale facility development underscores the momentum behind commercialisation.
Behind the operational progress, SEDI filings reveal that CFO Mena Beshay has deployed six figures of personal capital into Aduro shares over the past year, a pattern of consistent insider accumulation that began when he joined the company in 2022 with a $105,000 private placement subscription on day one.
For Yazan Al Homsi, the Aduro investment represents the intersection of two themes he has consistently emphasised: strong intellectual property protection and large total addressable markets. The company’s patented Hydrochemolytic Technology achieves a 95% yield rate on contaminated plastic waste streams that conventional recyclers cannot process, positioning it to capture value from European EPR mandates and the proposed CIRCLE Act in the United States.
Digital Healthcare: Rocket Doctor Scales Through Municipal Partnerships
Rocket Doctor AI announced its second Canadian municipal partnership on February 24, 2026, with Lethbridge County, Alberta. The deal provides more than 10,000 residents with virtual access to licensed Alberta physicians, fully covered by Alberta Health, with automatic two-year renewals.
The operational metrics support the expansion. Rocket Doctor served 16,417 patients in Alberta during Q3 2025, an 81% increase over Q3 2024. The platform has facilitated more than 700,000 patient visits through over 300 physicians, and has expanded into the United States with a major insurer contract covering 175,000 members in California.
Al Homsi’s investment thesis centres on the municipal partnership model as a scalable, capital-efficient revenue pathway. Rather than competing for individual consumers, the company partners with local governments that fund virtual care through provincial health budgets. This creates recurring, institutionally backed revenue tied to structural demand: approximately 6.5 million Canadians lack a regular family physician, with rural communities facing the most acute shortages.
Education Technology: EduMentors Prepares for AI Integration
The third sector in Al Homsi’s portfolio is education technology through his investment in EduMentors, a UK-based platform connecting students with qualified tutors. The company is preparing to launch AI-enhanced features designed to personalise the learning experience and improve educational outcomes at scale.
While earlier-stage than Aduro or Rocket Doctor, EduMentors operates in a market undergoing fundamental transformation. The global EdTech sector has been projected to exceed $400 billion by 2028, driven by demand for learning solutions that adapt to individual student needs. AI features capable of real-time feedback, personalised content delivery, and reduced administrative overhead represent structural improvements over traditional tutoring models.
For Al Homsi, the EduMentors investment extends the same thesis applied to his cleantech and healthcare holdings: technology platforms addressing measurable inefficiencies in essential services, designed to scale across geographic markets. The UK market provides a strong foundation for potential expansion into Gulf and broader international markets where demand for English-language educational platforms continues to grow.
The Cross-Border Advantage
What connects these investments beyond their sectoral focus is Al Homsi’s cross-border operating model. Vancouver ranks among North America’s most active ecosystems for cleantech and life sciences, while Dubai serves as the primary gateway for institutional capital across the Middle East. By maintaining operations in both cities, Al Homsi connects portfolio companies with capital sources and market access that single-geography investors typically cannot reach. His strategic investment in Charbone Hydrogen Corporation (TSXV: CH | OTCQB: CHHYF) further illustrates this approach, backing North America’s only publicly traded company devoted exclusively to green hydrogen production.
His track record supports the model. Al Homsi was involved in the growth trajectory of Medicago, which grew from a market capitalisation of under $10 million to $357 million before acquisition. That experience with small-cap companies achieving outsized outcomes through strategic positioning informs his current approach to Aduro, Rocket Doctor, and EduMentors.
Reading the Signals
The convergence of Q1 2026 milestones across Yazan Al Homsi’s portfolio illustrates a broader pattern in capital deployment. The companies achieving commercial traction are not those building AI as an end product but those embedding AI into the infrastructure of essential industries.
Chemical recycling requires AI-enhanced process optimisation to achieve the yield rates that regulatory compliance demands. Virtual healthcare requires AI-powered decision support to extend physician capacity across underserved geographies. Education technology requires AI-driven personalisation to scale beyond one-to-one tutoring.
In each case, the AI layer is not the product itself but the enabler of a business model addressing structural demand. For investors tracking where smart capital is heading in 2026, the pattern across Al Homsi’s portfolio provides a clear signal: the returns in AI may not come from the technology itself but from the physical industries it transforms.
Disclaimer: This article has been prepared for informational purposes only and does not represent financial, investment, or legal advice of any kind. The opinions expressed herein are the author’s own and should not be attributed to any person, company, or organisation referenced. Readers are advised to consult qualified professionals and conduct independent research before making investment decisions.
